The Architecture of the TIR Domain Signalosome in the Toll-like Receptor-4 Signaling Pathway

Activated Toll-like receptors (TLRs) cluster in lipid rafts and induce pro- and anti-tumor responses. The organization of the assembly is critical to the understanding of how these key receptors control major signaling pathways in the cell. Although several models for individual interactions were proposed, the entire TIR-domain signalosome architecture has not been worked out, possibly due to its complexity. We employ a powerful algorithm, crystal structures and experimental data to model the TLR4 and its cluster. The architecture that we obtain with 8 MyD88 molecules provides the structural basis for the MyD88-templated myddosome helical assembly and receptor clustering; it also provides clues to pro- and anti-inflammatory signaling pathways branching at the signalosome level to Mal/MyD88 and TRAM/TRIF pro- and anti-inflammatory pathways. The assembly of MyD88 death domain (DD) with TRAF3 (anti-viral/anti-inflammatory) and TRAF6 (pro-inflammatory) suggest that TRAF3/TRAF6 binding sites on MyD88 DD partially overlap, as do IRAK4 and FADD. Significantly, the organization illuminates mechanisms of oncogenic mutations, demonstrates that almost all TLR4 parallel pathways are competitive and clarifies decisions at pathway branching points. The architectures are compatible with the currently-available experimental data and provide compelling insights into signaling in cancer and inflammation pathways.

[1]  F. Martinon,et al.  MyD88, an Adapter Protein Involved in Interleukin-1 Signaling* , 1998, The Journal of Biological Chemistry.

[2]  E. Kieff,et al.  The structural basis for the recognition of diverse receptor sequences by TRAF2. , 1999, Molecular cell.

[3]  Young Chul Park,et al.  A Novel Mechanism of TRAF Signaling Revealed by Structural and Functional Analyses of the TRADD–TRAF2 Interaction , 2000, Cell.

[4]  J C Reed,et al.  Molecular basis for CD40 signaling mediated by TRAF3. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  L. Tong,et al.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.

[6]  Hao Wu,et al.  Molecular basis for CD 40 signaling mediated by TRAF 3 , 2000 .

[7]  Chen Dong,et al.  MAP kinases in the immune response. , 2002, Annual review of immunology.

[8]  Hao Wu,et al.  Distinct molecular mechanism for initiating TRAF6 signalling , 2002, Nature.

[9]  J. Tschopp,et al.  MyD88S, a splice variant of MyD88, differentially modulates NF‐κB‐ and AP‐1‐dependent gene expression , 2003, FEBS letters.

[10]  J. Khan,et al.  Crystal Structure of the Toll/Interleukin-1 Receptor Domain of Human IL-1RAPL* , 2004, Journal of Biological Chemistry.

[11]  C. Ni,et al.  Key Molecular Contacts Promote Recognition of the BAFF Receptor by TNF Receptor-Associated Factor 3: Implications for Intracellular Signaling Regulation1 , 2004, The Journal of Immunology.

[12]  S. Ibrahim,et al.  Fas ligation on macrophages enhances IL-1R1–Toll-like receptor 4 signaling and promotes chronic inflammation , 2004, Nature Immunology.

[13]  C. Ni,et al.  LMP 1 PROTEIN FROM THE EPSTEIN BARR VIRUS IS A STRUCTURAL CD 40 DECOY IN B LYMPHOCYTES FOR BINDING TO TRAF 3 * , 2005 .

[14]  C. Ni,et al.  LMP1 Protein from the Epstein-Barr Virus Is a Structural CD40 Decoy in B Lymphocytes for Binding to TRAF3* , 2005, Journal of Biological Chemistry.

[15]  R. Medzhitov,et al.  Phosphoinositide-Mediated Adaptor Recruitment Controls Toll-like Receptor Signaling , 2006, Cell.

[16]  M. Mann,et al.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.

[17]  C. Benedict,et al.  A TRAFfic cop for host defense , 2006, Nature Immunology.

[18]  N. Gay,et al.  A Dimer of the Toll-Like Receptor 4 Cytoplasmic Domain Provides a Specific Scaffold for the Recruitment of Signalling Adaptor Proteins , 2007, PloS one.

[19]  Grazia Gallo,et al.  Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound , 2007, Journal of leukocyte biology.

[20]  L. O’Neill,et al.  Signalling adaptors used by Toll-like receptors: an update. , 2008, Cytokine.

[21]  S. Akira,et al.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.

[22]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[23]  C. Robinson,et al.  An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4* , 2009, The Journal of Biological Chemistry.

[24]  M. Shirakawa,et al.  Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling , 2009, Proceedings of the National Academy of Sciences.

[25]  R. Medzhitov,et al.  Toll-like receptors and cancer , 2009, Nature Reviews Cancer.

[26]  M. Karin,et al.  Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines , 2010, Nature Immunology.

[27]  Yang Zhang,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[28]  Ozlem Keskin,et al.  HotPoint: hot spot prediction server for protein interfaces , 2010, Nucleic Acids Res..

[29]  Y. Lo,et al.  Helical assembly in the MyD88:IRAK4:IRAK2 complex in TLR/IL-1R signaling , 2010, Nature.

[30]  L. Tourneur,et al.  FADD: a regulator of life and death. , 2010, Trends in immunology.

[31]  A. Mansell,et al.  TIR-containing adaptors in Toll-like receptor signalling. , 2010, Cytokine.

[32]  Sangdun Choi,et al.  In Silico Approach to Inhibition of Signaling Pathways of Toll-Like Receptors 2 and 4 by ST2L , 2011, PloS one.

[33]  François Stricher,et al.  A graphical interface for the FoldX forcefield , 2011, Bioinform..

[34]  R. Nussinov,et al.  Predicting protein-protein interactions on a proteome scale by matching evolutionary and structural similarities at interfaces using PRISM , 2011, Nature Protocols.

[35]  Anne-Sophie de Smet,et al.  Identification of Interaction Sites for Dimerization and Adapter Recruitment in Toll/Interleukin-1 Receptor (TIR) Domain of Toll-like Receptor 4* , 2011, The Journal of Biological Chemistry.

[36]  M. Karin,et al.  Expanding TRAF function: TRAF3 as a tri-faced immune regulator , 2011, Nature Reviews Immunology.

[37]  F. DiMaio,et al.  Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection , 2011, Proceedings of the National Academy of Sciences.

[38]  Wei Hu,et al.  Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt , 2011, Proceedings of the National Academy of Sciences.

[39]  D. Davies,et al.  The structural biology of Toll-like receptors. , 2011, Structure.

[40]  Hao Wu,et al.  Structural Insights into the Assembly of Large Oligomeric Signalosomes in the Toll-Like Receptor–Interleukin-1 Receptor Superfamily , 2012, Science Signaling.

[41]  Weihong Zhou,et al.  Structural Insights into TIR Domain Specificity of the Bridging Adaptor Mal in TLR4 Signaling , 2012, PloS one.

[42]  G. Cheng,et al.  Single Amino Acid Substitutions Confer the Antiviral Activity of the TRAF3 Adaptor Protein onto TRAF5 , 2012, Science Signaling.

[43]  Z. Zhou,et al.  Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure. , 2012, Journal of molecular biology.

[44]  G. Trinchieri Cancer and inflammation: an old intuition with rapidly evolving new concepts. , 2012, Annual review of immunology.

[45]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[46]  R. Jerala,et al.  Toll/Interleukin-1 Receptor Domain Dimers as the Platform for Activation and Enhanced Inhibition of Toll-like Receptor Signaling* , 2012, The Journal of Biological Chemistry.

[47]  Benjamin A. Shoemaker,et al.  Cancer Missense Mutations Alter Binding Properties of Proteins and Their Interaction Networks , 2013, PloS one.

[48]  P. Dijke,et al.  UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination , 2013, Cell Research.

[49]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[50]  Shannon K. Stefl,et al.  Molecular mechanisms of disease-causing missense mutations. , 2013, Journal of molecular biology.

[51]  Erik Verschueren,et al.  Integration of Protein Abundance and Structure Data Reveals Competition in the ErbB Signaling Network , 2013, Science Signaling.

[52]  E. Sundberg,et al.  Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain , 2013, Proceedings of the National Academy of Sciences.

[53]  Ozlem Keskin,et al.  The structural network of inflammation and cancer: merits and challenges. , 2013, Seminars in cancer biology.

[54]  Hao Wu,et al.  Higher-Order Assemblies in a New Paradigm of Signal Transduction , 2013, Cell.

[55]  Thomas Miethke,et al.  Crystal Structures of the Toll/Interleukin-1 Receptor (TIR) Domains from the Brucella Protein TcpB and Host Adaptor TIRAP Reveal Mechanisms of Molecular Mimicry* , 2013, The Journal of Biological Chemistry.

[56]  Douglas Golenbock,et al.  The history of Toll-like receptors — redefining innate immunity , 2013, Nature Reviews Immunology.

[57]  J. Tavernier,et al.  Identification of Binding Sites for Myeloid Differentiation Primary Response Gene 88 (MyD88) and Toll-like Receptor 4 in MyD88 Adapter-like (Mal)* , 2013, The Journal of Biological Chemistry.

[58]  D. Standley,et al.  Structures and interface mapping of the TIR domain-containing adaptor molecules involved in interferon signaling , 2013, Proceedings of the National Academy of Sciences.

[59]  Ozlem Keskin,et al.  PRISM: a web server and repository for prediction of protein–protein interactions and modeling their 3D complexes , 2014, Nucleic Acids Res..

[60]  R. Schwabe,et al.  The Yin and Yang of Toll-like receptors in cancer , 2014, Oncogene.

[61]  Hao Wu,et al.  Promiscuity is not always bad. , 2014, Molecular cell.

[62]  Martyn F. Symmons,et al.  Assembly and localization of Toll-like receptor signalling complexes , 2014, Nature Reviews Immunology.